MONTREAL, QUEBEC -- (MARKET WIRE) -- April 02, 2007 -- Mistral Pharma Inc. (TSX VENTURE: MIP) ("Mistral") announces today that it has entered into an agreement for the acquisition of 100% of the shares of CuraMedica (Canada) Inc., (CuraMedica) a privately-held Montreal company that own the Canadian rights for pharmaceutical products in different therapeutic areas. One of these products, Instillagel® is expected to be approved by Health Canada in 2007.
